Phase II trial of cat allergy vaccine (Cat-PAD) in patients with hypersensitivity to cat dander.

Trial Profile

Phase II trial of cat allergy vaccine (Cat-PAD) in patients with hypersensitivity to cat dander.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2008

At a glance

  • Drugs Cat SPIRE (Primary) ; Cat SPIRE (Primary)
  • Indications Hypersensitivity
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Circassia
  • Most Recent Events

    • 10 Sep 2008 Results reported in a Circassia media release.
    • 03 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top